AN2 Therapeutics, Inc. (ANTX) — Analyst estimates
Consensus analyst estimates for AN2 Therapeutics, Inc. — earnings, revenue, and price targets.
| Fiscal Year | Revenue Forecast | EPS Forecast | analysts |
|---|---|---|---|
| 2026 | 0 | -0.25 | 1 |
| 2027 | 217M | -1.04 | 1 |
| 2028 | 389.9M | -1.02 | 1 |
Consensus analyst estimates by fiscal year.